Riskpilot← Back to searchSign inGet full accessBiotrans i Nord AB
ABActiveOrg 5567959506Åkerivägen 12Freight transport by road · NACE 4941Est. 20095-9 employees
Revenue 2024
SEK 11,6M
+11% vs 2023
EBITDA margin
11.8%
+1176% vs 2023
Equity ratio
4.2%
Financial strength
Net profit 2024
SEK -25K
-933% vs 2023
| Revenue | SEK 11,6M | +11% |
| EBITDA | SEK 1,4M | +1176% |
| Net profit | SEK -25K | -933% |
| Total assets | SEK 14,9M | -19% |
| Equity | SEK 625K | -4% |
| Employees | — | — |
Legal name
Biotrans i Nord AB
Org number
5567959506
Legal form
Aktiebolag
NACE code
4941 · Freight transport by road
Founded
3 december 2009
Share capital
SEK 500 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva och utveckla maskinarbeten samt transporter avseende skogs-, bioenergi-, pappers- och massaprodukter, samt därmed förenlig verksamhet.
Address
Åkerivägen 12
Email
par@norrlandsjord.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 12 606 | 15 324 | 14 969 | 10 424 | 11 614 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 137 | 1 392 | 1 114 | −127 | 1 367 |
| Depreciation & amort. | −955 | −1 298 | −1 498 | −1 614 | −1 969 |
| EBIT | 182 | 94 | −384 | −1 741 | −602 |
| Net financials | −113 | −93 | −153 | −291 | −393 |
| Profit before tax | 9 | 2 | 4 | 3 | −25 |
| Tax | −3 | −1 | −0 | −0 | −0 |
| Net profit | 6 | 1 | 4 | 3 | −25 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 10 924 | 11 243 | 13 409 | 18 335 | 14 910 |
| Equity | 642 | 643 | 647 | 650 | 625 |
| Long-term debt | 5 898 | 6 130 | 8 021 | 12 599 | 10 740 |
| Short-term debt | 3 728 | 3 814 | 4 626 | 5 086 | 3 545 |
| Total debt | 9 626 | 9 944 | 12 647 | 17 685 | 14 285 |
EBITDA margin
11.8%
This company
15.8%
Market median
-25% vs market
20202024
Equity ratio
4.2%
This company
38.2%
Market median
-89% vs market
20202024
Return on equity
-4.0%
This company
18.4%
Market median
-122% vs market
20202024
Net profit margin
-0.2%
This company
8.1%
Market median
-102% vs market
20202024
Asset turnover
0.78×
This company
1.12×
Market median
-30% vs market
20202024
Debt / equity
22.86×
This company
0.62×
Market median
-3587% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
KL Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2020 |
PD Chief Executive Officer | Chief Executive Officer | 2020 |
ST Chief Auditor | Chief Auditor | 2022 |
| Former (2) | ||
UT Chief Auditor | Chief Auditor | 2020 – 2022 |
AK Chief Auditor | Chief Auditor | 2020 – 2020 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Energi & Miljöprojekt i Nord AB
Biotrans i Nord AB Board members of Biotrans i Nord AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kurt Lennart Johansson | Deputy Chief Executive Officer | 0 companies |
| Ulf Thomas Taavo | Chief Auditor | 0 companies |
| Pär Dinesh Kumara Johansson | Chief Executive Officer | 0 companies |
| Anna Katarina Enbom | Chief Auditor | 0 companies |
| Sven Tommy Enstedt | Chief Auditor | 0 companies |